HESTERBIOUpdated 31 Aug 2026, 20:53

Hester Biosciences Ltd

HESTERBIOUpdated 31 Aug 2026, 20:53

Market Cap

₹1,926Cr.

Current Price

₹2,259

High / Low

₹2,684/1,239

Stock P/E

35.9

ROE13.0%

ROCE15.5%

Book Value₹453

Face Value₹10.0

Dividend Yield0.49%

About

Incorporated in 1987, Hester Biosciences Ltd is one of India’s leading animal healthcare companies and a major manufacturer of poultry and animal vaccines, including a leading position in PPR and Goat Pox vaccines.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	72	95	79	86	70	96	80	95	118	110	103	115
Inventory Days	431	627	356	493	511	754	390	404	362	251	228	267
Days Payable	68	109	80	100	85	170	96	63	131	110	127	92
Cash Conversion Cycle	434	614	355	480	496	681	374	436	349	250	204	290
Working Capital Days	55	89	87	94	123	129	182	149	106	130	110	117
ROCE %	18%	22%	24%	26%	31%	20%	25%	17%	12%	9%	11%	16%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 31 August 2026 at 20:53

HESTER BIOSCIENCES LTD (HESTERBIO) financials — quarterly results, P&L, cash flow, balance sheet, shareholding